Growing community of inventors

Munich, Germany

Mark Winderlich

Average Co-Inventor Count = 3.89

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 25

Mark WinderlichJan Endell (7 patents)Mark WinderlichRainer Boxhammer (7 patents)Mark WinderlichLisa Rojkjaer (4 patents)Mark WinderlichChristofer Samuelsson (4 patents)Mark WinderlichStefan Steidl (2 patents)Mark WinderlichJutta Amersdorfer (0 patent)Mark WinderlichSusanne Krohn (2 patents)Mark WinderlichJutta Amersdorfer (1 patent)Mark WinderlichLisa Rojkjaer (1 patent)Mark WinderlichDominika Weinelt (0 patent)Mark WinderlichSteffen Heeger (0 patent)Mark WinderlichPeter Kelemen (0 patent)Mark WinderlichJutta Amersdorffer (1 patent)Mark WinderlichMichael Schwarz (0 patent)Mark WinderlichJutta Amersdorffer (0 patent)Mark WinderlichSusanne Krohn (0 patent)Mark WinderlichMark Winderlich (7 patents)Jan EndellJan Endell (11 patents)Rainer BoxhammerRainer Boxhammer (8 patents)Lisa RojkjaerLisa Rojkjaer (5 patents)Christofer SamuelssonChristofer Samuelsson (4 patents)Stefan SteidlStefan Steidl (6 patents)Jutta AmersdorferJutta Amersdorfer (0 patent)Susanne KrohnSusanne Krohn (2 patents)Jutta AmersdorferJutta Amersdorfer (1 patent)Lisa RojkjaerLisa Rojkjaer (1 patent)Dominika WeineltDominika Weinelt (0 patent)Steffen HeegerSteffen Heeger (0 patent)Peter KelemenPeter Kelemen (0 patent)Jutta AmersdorfferJutta Amersdorffer (1 patent)Michael SchwarzMichael Schwarz (0 patent)Jutta AmersdorfferJutta Amersdorffer (0 patent)Susanne KrohnSusanne Krohn (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Morphosys Ag (6 from 88 patents)

2. Incyte Corporation (1 from 666 patents)


7 patents:

1. 12194095 - Combinations and uses thereof

2. 11224654 - Combinations and uses thereof

3. 10617691 - Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof

4. 10308722 - Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

5. 9765152 - Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib

6. 9289490 - Combinations and uses thereof

7. 8877899 - Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…